| Metric | Value (₹ Cr) |
|---|---|
| Revenue | 1.1K |
| Total Income | 1.1K |
| Expenditure | 857.72 |
| PBT | 291.67 |
| Net Profit | 237.86 |
| OPM | 35.31% |
| NPM | 20.69% |
| EPS | 4.01 |
Emmvee Photovoltaic Power Reports 193% YoY H1 Revenue Surge to ₹ 2,159 Crore; PAT Jumps Nearly 7x
02 Dec 2025 · 2 Dec 2025, 02:02 am
Summary
Emmvee Photovoltaic Power Limited, a leading Indian renewable energy company, reported its un-audited consolidated financial results for the second quarter (Q2 FY26) and half-year (H1 FY26) ended September 30, 2025. The company witnessed a significant surge in demand for high-efficiency solar modules, driving a 193% year-on-year increase in H1 revenue. The strong topline performance was complemented by operational efficiencies, resulting in significant EBITDA margin expansion. Subsequent to the quarter end, Emmvee successfully completed its Initial Public Offering (IPO), raising a total of 2,900 Crore.
Key Highlights
- 1
Revenue from Operations for H1 FY26 grew 193% YoY to ₹ 2,159 Crore
- 2
H1 PAT jumped nearly 7x to ₹ 425.5 Crore
- 3
Photovoltaic (PV) Module segment continues to drive growth with substantial order execution
- 4
Successfully completed IPO raising ₹ 2,900 Crore
- 5
A large part of the IPO proceeds have been used to repay about ₹ 1,621 crore of long-term debt
- 6
Emmvee is strategically positioned to capture significant market share with advanced technology and integrated manufacturing ecosystem
Management Comments
Mr. Manjunatha Donthi Venkatarathnaiah
We are delighted to report a historic first half for Emmvee, characterized by record financial performance and our successful transition into a publicly listed entity. Delivering a nearly 7x growth in Profit After Tax for the first half of the year is a testament to our robust manufacturing capabilities and the trust our customers place in our high-quality solar solutions. With the successful completion of our IPO, we are better capitalized than ever to execute our expansion strategies.
Informational and educational content only. Not investment advice.